Lido Advisors, LLC Annexon, Inc. Transaction History
Lido Advisors, LLC
- $25.9 Billion
- Q2 2025
A detailed history of Lido Advisors, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Lido Advisors, LLC holds 35,000 shares of ANNX stock, worth $110,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,000
Previous 20,000
75.0%
Holding current value
$110,250
Previous $38,000
121.05%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ANNX
# of Institutions
142Shares Held
96.5MCall Options Held
0Put Options Held
63.4K-
Satter Management Co., L.P.7.41MShares$23.3 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$22.1 Million0.66% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$20.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$19.8 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$16.9 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $150M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...